e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Translational research to bridge the need within clinical decision making
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of transcription factors ASCL1 and HES1 expression in diffuse idiopathic neuroendocrine cell hyperplasia (DIPNECH) and pulmonary carcinoids
B. Ebert, F. Bari, D. Snead, D. Mitchell (Coventry, United Kingdom)
Source:
Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Session:
Translational research to bridge the need within clinical decision making
Session type:
Thematic Poster Session
Number:
535
Disease area:
Interstitial lung diseases, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Ebert, F. Bari, D. Snead, D. Mitchell (Coventry, United Kingdom). Role of transcription factors ASCL1 and HES1 expression in diffuse idiopathic neuroendocrine cell hyperplasia (DIPNECH) and pulmonary carcinoids. Eur Respir J 2013; 42: Suppl. 57, 535
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Clinicopathological prognostic factors in operated for small cell lung carcinoma or large cell neuroendocrine carcinoma patients
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Correlation between clinical and pathological factors in resected lung carcinoid tumours
Source: International Congress 2016 – Special issues in thoracic surgery
Year: 2016
Micro-RNA screening in neuroendocrine lung tumors: Differential expression of miR-29 family members
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Distinct gene expression profiles of cultured stromal cells from the patients with idiopathic pulmonary fibrosis and lung adenocarcinoma
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
The proteasome subunits PSMA5 and PSMB4 are potent markers to discriminate between typical and atypical carcinoid tumors of the lung
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
Primary lung sarcomas and sarcomatoid carcinomas – Clinicopathological prognostic factors in operated patients
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
Intrathoracic mass as an initial presentation of follicular carcinoma of thyroid: A rare entity
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015
The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013
Regulation and localization of the telomerase enzyme-complex and the shelterin-telosom-complex in sporadic idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013
Immunoglobulin-like transcripts 3 (ILT3) expression in human lung adenocarcinoma as a novel regulator of intratumoral lymphoid follicle formation
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Increased sirtuin expression in patient with lung squamous cell carcinoma co-morbid with COPD
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Multiple endobronchial involvement of Mantle cell lymphoma diagnosed by cryobiopsy
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
Reactive oxygen species modulator 1 (Romo1) as a diagnostic marker for lung cancer-related malignant effusion
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016
Incidence, outcomes and risk factors for neoplasms in explanted lungs
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
Neuroendocrine cell hyperplasia (NEHI) and NEHI Syndrome: Lung biopsy necessary?
Source: International Congress 2014 – ILDs 4
Year: 2014
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour
Source: Eur Respir J, 59 (1) 2101058; 10.1183/13993003.01058-2021
Year: 2022
Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Secreted frizzled-related protein 1 (Sfrp1) as key mediator of growth-factor induced invasion
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Prognostic factors in non-small cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept